Cross-sectional analysis of late HARRT initiation in Latin America and the Caribbean: Late testers and late presenters
Author
dc.contributor.author
Crabtree Ramírez, Brenda
Author
dc.contributor.author
Caro Vega, Yanink
Author
dc.contributor.author
Shepherd, Bryan E.
Author
dc.contributor.author
Wehbe, Firas
Author
dc.contributor.author
Cesar, Carina
Author
dc.contributor.author
Cortés, Claudia
Author
dc.contributor.author
Padgett, Denis
Author
dc.contributor.author
Koenig, Serena
Author
dc.contributor.author
Gotuzzo, Eduardo
Author
dc.contributor.author
Cahn, Pedro
Author
dc.contributor.author
McGowan, Catherine C.
Author
dc.contributor.author
Masys, Daniel
Author
dc.contributor.author
Sierra Madero, Juan Juan
Author
dc.contributor.author
The CCASAnet Team,
Admission date
dc.date.accessioned
2019-03-11T13:01:41Z
Available date
dc.date.available
2019-03-11T13:01:41Z
Publication date
dc.date.issued
2011
Cita de ítem
dc.identifier.citation
PLoS ONE, Volumen 6, Issue 5, 2018,
Identifier
dc.identifier.issn
19326203
Identifier
dc.identifier.other
10.1371/journal.pone.0020272
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/165244
Abstract
dc.description.abstract
Background: Starting HAART in a very advanced stage of disease is assumed to be the most prevalent form of initiation in HIV-infected subjects in developing countries. Data from Latin America and the Caribbean is still lacking. Our main objective was to determine the frequency, risk factors and trends in time for being late HAART initiator (LHI) in this region. Methodology: Cross-sectional analysis from 9817 HIV-infected treatment-naïve patients initiating HAART at 6 sites (Argentina, Chile, Haiti, Honduras, Peru and Mexico) from October 1999 to July 2010. LHI had CD4+ count ≤200cells/mm3 prior to HAART. Late testers (LT) were those LHI who initiated HAART within 6 months of HIV diagnosis. Late presenters (LP) initiated after 6 months of diagnosis. Prevalence, risk factors and trends over time were analyzed. Principal Findings: Among subjects starting HAART (n = 9817) who had baseline CD4+ available (n = 8515), 76% were LHI: Argentina (56%[95%CI:52-59]), Chile (80%[95%CI:77-82]), Haiti